Cargando…

485. Pediatrics Institutional COVID-19 Review

BACKGROUND: Coronavirus disease (COVID-19) caused by SARS-COV2 represents global public health concern, with varied severity of illness in different ages and racial groups. This study aims to describe clinical presentation and outcomes in children aged 0-21 years in a community hospital setting in N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karna, Prakash, Farrand, Lauren, Hasan, Uzma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644804/ http://dx.doi.org/10.1093/ofid/ofab466.684

Ejemplares similares

1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different?
por: Bhargava, Aakriti, et al.
Publicado: (2021)

485. Title: The Porous Boundaries Between Communities and Correctional Facilities: The Introduction of a Medical Recovery Site Resulting in Reduced COVID-19 Household Transmission Tied to Recently Incarcerated Individuals
por: Pocock, Katherine, et al.
Publicado: (2020)

485. Clinical and Molecular Epidemiology of Carbapenem Non-susceptible Citrobacter sp.
por: Babiker, Ahmed, et al.
Publicado: (2019)

1212. COVID-19 and the Importance of Institutional Trust to Public Health
por: Kricorian, Karin, et al.
Publicado: (2021)

485. On- and Post-Antibiotic Effects on the Risk of Hospital-Acquired Clostridium difficile Infection (CDI)
por: Stevens, Vanessa, et al.
Publicado: (2018)

487. Patient Outcomes of Contact Tracing for COVID-19 in a Pediatric Hospital
por: Smathers, Sarah, et al.
Publicado: (2020)

Symphonie no. 5 D485 Symphonie no. 6 D485 /
por: Schubert, Franz, 1797-1828
Publicado: (1988)

1349. Institutional Antibiograms Are Insufficient to Guide Clindamycin Use in Pediatric Skin and Soft Tissue Infections
por: Firmani, Sarah E, et al.
Publicado: (2020)

PM485. Association between erythrocyte membrane fatty acids and psychopathology in individuals at ultra-high risk for psychosis
por: Jhon, Min, et al.
Publicado: (2016)

548. Convalescent Plasma in Hospitalized Pediatric and Obstetric patients with COVID-19
por: Ikeda, Saki, et al.
Publicado: (2021)

485 Chronic sequelae of SARS-CoV-2 in the Scnn1b-Tg mouse model of cystic fibrosis lung disease
por: Hawkins, P., et al.
Publicado: (2022)

132. Standardized Antimicrobial Administration Ratios to Guide Antimicrobial Stewardship in the Neonatal Intensive Care Unit: a Single Center Experience
por: Smoke, Steven, et al.
Publicado: (2021)

COM6 /485: Dermis.net - from a Dermatology Internet Atlas to a Dermatology Internet Portal Site
por: Eysenbach, G, et al.
Publicado: (1999)

604. Impact of COVID-19 Pandemic on Telehealth Practices in Pediatric Infectious Diseases
por: Mohandas, Sindhu, et al.
Publicado: (2021)

Waiting Lists and Pandemics: A Prospective Multi-Institutional Study on The Impact Of Covid-19 on a Tertiary Referral Urology Centre
por: Anderson, S., et al.
Publicado: (2020)

1345. Impact of the COVID-19 Pandemic on Pediatric Ambulatory Antibiotic Use in an Academic Health System
por: Katz, Sophie E, et al.
Publicado: (2020)

496. Comparison of Severe COVID 19 and Influenza Infections in Pediatric Patients Requiring PICU in Bogota, Colombia
por: Gutiérrez Tobar, Ivan Felipe, et al.
Publicado: (2021)

485 Colistin Nephrotoxicity in Critically Ill Patients after Implementation of a New Dosing Strategy
por: Özel, Ayşe Serra, et al.
Publicado: (2014)

361. Aseptic Meningitis Associated to SARS Cov2 Infection and MIS-C: Pediatric Presentation of Covid-19
por: Quintero, Mónica J Olguín, et al.
Publicado: (2021)

1179. PCV13 Pediatric Routine Schedule Completion and Adherence Before and During the COVID-19 Pandemic in the US
por: Huang, Liping, et al.
Publicado: (2021)

315. A Multi-center Study to Describe Obese Pediatric Patients with COVID-19 Across the United States
por: Hammoud, Roukaya Al, et al.
Publicado: (2021)

526. Clinical Presenting Characteristics of Pediatric COVID-19 Infection in a Tertiary Care Children’s Hospital in Detroit
por: Ang, Jocelyn Y, et al.
Publicado: (2020)

386. A Systematic Review of COVID-19 Transmission Dynamics and Clinical Response on Cruise Ships Globally Between January and October 2020
por: Willebrand, Kathryn, et al.
Publicado: (2021)

P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY
por: Short, Nicholas, et al.
Publicado: (2023)

364. Individualized Prognostics in COVID-19 Facilitated by Computer Recognition of Blood Leukocyte Subsets
por: Libertin, Claudia R, et al.
Publicado: (2021)

441. Clinical Characteristics of Pediatric SARS-CoV-2 Infection and Coronavirus Disease 2019 (COVID-19) in Kuwait
por: Alsharrah, Danah Y, et al.
Publicado: (2020)

1727. Household Vaccination Status and Attitudes towards Pediatric COVID-19 Vaccination: A survey at four New Jersey clinic-based pediatric practices
por: Katic, Bozena J, et al.
Publicado: (2023)

Institutional change and Institutional Integration in France: Health Regional Agencies. What consequences for the development integrated services delivery?
por: Trouvé, Hélène, et al.
Publicado: (2012)

194. Antibiotic-resistant bloodstream infections in pediatric oncology patients on levofloxacin prophylaxis
por: Sridhar, Sunita, et al.
Publicado: (2020)

Sa1066: SURVEY OF NYC PEDIATRIC INSTITUTIONS SUGGESTS POSSIBLE INCREASE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE DIAGNOSIS ASSOCIATED WITH PREVALENCE OF COVID INFECTION
por: Ochoa, Kenny J. Castro, et al.
Publicado: (2022)

572. Antiviral Toxicities Among Pediatric Solid Organ Transplant Recipients
por: Downes, Kevin J, et al.
Publicado: (2020)

1200. Risk of group A streptococcal Transmission Among the Pediatric Population in the Houston Area
por: Alamarat, zain I, et al.
Publicado: (2020)

558. Innovative CME Tools in the Teaching of Evolving Strategies in the Management and Prevention of COVID-19
por: Hanson, Brianna, et al.
Publicado: (2020)

441. The Effects of Race and Comorbidity Burden on Inflammatory Biomarkers Among Persons Hospitalized with COVID-19
por: Fatade, Yetunde A, et al.
Publicado: (2021)

476. Gilead Sciences’ Commitment to the COVID-19 Pandemic
por: Lee, EunYoung, et al.
Publicado: (2020)

349. Diagnostic Testing and Antibiotic Utilization in Patients with COVID-19
por: Groft, Lauren, et al.
Publicado: (2021)

446. COVID 19 Pandemicity: a global situation report as of June 9, 2020
por: Sanyaolu, Adekunlle, et al.
Publicado: (2020)

485. Improved Outcome of COVID-19 in CAR T Cell Treated Patients; results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
por: Ljungman, Per, et al.
Publicado: (2023)

Quantification of Neutrophil Extracellular Traps (NETs) in Pediatric Patients with COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) through Plasma and Peripheral Smear Analysis
por: Thompson, Rachelle, et al.
Publicado: (2022)

JBP485 promotes corneal epithelial wound healing
por: Nagata, Maho, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o818erb2c3o5d5tna6q8iks6pp